مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
Click here for full text options
LibKey Link

مصطلحات الفهرس: male, malignant neoplasm/dt [Drug Therapy], medication compliance, medication error, medication therapy management, metastasis/dt [Drug Therapy], multiple cycle treatment, multiple myeloma/dt [Drug Therapy], pneumocystosis/dt [Drug Therapy], pneumocystosis/pc [Prevention], potentially inappropriate medication, quality control, randomized controlled trial (topic), review, solid malignant neoplasm/dt [Drug Therapy], stomach cancer/dt [Drug Therapy], systematic review, teleconsultation, thrombosis prevention, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], abiraterone/dt [Drug Therapy], abiraterone/pv [Special Situation for Pharmacovigilance], antiemetic agent/ae [Adverse Drug Reaction], antiemetic agent/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], antiinfective agent, antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/po [Oral Drug Administration], antineoplastic agent/pa [Parenteral Drug Administration], antineoplastic agent/pv [Special Situation for Pharmacovigilance], antithrombocytic agent/dt [Drug Therapy], bicalutamide/dt [Drug Therapy], bicalutamide/pv [Special Situation for Pharmacovigilance], bisphosphonic acid derivative, calcium, corticosteroid, dexamethasone/pv [Special Situation for Pharmacovigilance], enzalutamide/dt [Drug Therapy], enzalutamide/pv [Special Situation for Pharmacovigilance], erlotinib/pv [Special Situation for Pharmacovigilance], gefitinib/pv [Special Situation for Pharmacovigilance], gimeracil plus oteracil potassium plus tegafur/dt [Drug Therapy], gimeracil plus oteracil potassium plus tegafur/pv [Special Situation for Pharmacovigilance], influenza vaccine, ondansetron/pv [Special Situation for Pharmacovigilance], vitamin D, drug choice, adjuvant chemotherapy, adjuvant therapy, adult, adverse drug reaction/si [Side Effect], aged, antibiotic prophylaxis, cancer chemotherapy, cancer immunotherapy, cancer palliative therapy, castration resistant prostate cancer/dt [Drug Therapy], chemotherapy induced nausea and vomiting/dt [Drug Therapy], chemotherapy induced nausea and vomiting/si [Side Effect], clinical pharmacy, controlled study, corticosteroid therapy, drug interaction, female, follow up, health care planning, human, influenza vaccination, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28684Test
Journal of Pharmacy Practice and Research
LibKey Link

مصطلحات الفهرس: drug blood level, drug dose escalation, drug safety, drug tolerability, human, maximum tolerated dose, phase 1 clinical trial, phase 2 clinical trial, priority journal, solid malignant neoplasm/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/pd [Pharmacology], cyclodextrin, docetaxel/dt [Drug Therapy], macrogol, nanoparticle, antineoplastic agent/cr [Drug Concentration], antineoplastic activity, article, advanced cancer, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39641Test
Annals of Oncology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug blood level, drug dose escalation, drug safety, drug tolerability, human, maximum tolerated dose, phase 1 clinical trial, phase 2 clinical trial, priority journal, solid malignant neoplasm/dt [Drug Therapy], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cm [Drug Comparison], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], antineoplastic agent/pd [Pharmacology], cyclodextrin, docetaxel/dt [Drug Therapy], macrogol, nanoparticle, antineoplastic agent/cr [Drug Concentration], antineoplastic activity, article, advanced cancer, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39641Test
Annals of Oncology
LibKey Link

مصطلحات الفهرس: cisplatin/dt [Drug Therapy], adult, aged, alopecia/co [Complication], alopecia/si [Side Effect], anemia/co [Complication], anemia/si [Side Effect], anorexia/si [Side Effect], article, bleeding/co [Complication], bleeding/si [Side Effect], cancer chemotherapy, cancer radiotherapy, cancer staging, cancer survival, clinical article, clinical trial, controlled clinical trial, controlled study, diarrhea/si [Side Effect], dose calculation, dose response, drug safety, edema/co [Complication], cisplatin/ae [Adverse Drug Reaction], cisplatin/cb [Drug Combination], cisplatin/do [Drug Dose], cisplatin/iv [Intravenous Drug Administration], paclitaxel/ae [Adverse Drug Reaction], paclitaxel/cb [Drug Combination], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], paclitaxel/iv [Intravenous Drug Administration], esophagitis/co [Complication], esophagitis/si [Side Effect], female, hiccup/si [Side Effect], human, human tissue, hyperglycemia/si [Side Effect], infection/si [Side Effect], insomnia/si [Side Effect], lung disease/si [Side Effect], lung non small cell cancer/dt [Drug Therapy], lung non small cell cancer/rt [Radiotherapy], lymphadenopathy, malaise/si [Side Effect], male, multimodality cancer therapy, muscle injury/co [Complication], nausea/co [Complication], nausea/si [Side Effect], neuropathy/si [Side Effect], neutropenia/co [Complication], neutropenia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pleura effusion, priority journal, radiation dose, radiation pneumonia/co [Complication], radiation response, thrombocytopenia/co [Complication], thrombocytopenia/si [Side Effect], tinnitus/si [Side Effect], treatment outcome, treatment planning, vomiting/co [Complication], vomiting/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/cb [Drug Combination], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], carboplatin/ae [Adverse Drug Reaction], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32772Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pd [Pharmacology], CD34 antigen/ec [Endogenous Compound], doxorubicin/ae [Adverse Drug Reaction], doxorubicin/ct [Clinical Trial], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/do [Drug Dose], doxorubicin/dt [Drug Therapy], doxorubicin/pd [Pharmacology], ifosfamide/ae [Adverse Drug Reaction], ifosfamide/ct [Clinical Trial], ifosfamide/cb [Drug Combination], ifosfamide/cm [Drug Comparison], ifosfamide/do [Drug Dose], ifosfamide/dt [Drug Therapy], ifosfamide/pd [Pharmacology], mesna/cb [Drug Combination], mesna/dt [Drug Therapy], paclitaxel/cb [Drug Combination], paclitaxel/cm [Drug Comparison], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], paclitaxel/pd [Pharmacology], recombinant granulocyte colony stimulating factor, thiotepa/cb [Drug Combination], thiotepa/dt [Drug Therapy], paclitaxel/ct [Clinical Trial], adult, antineoplastic activity, article, breast cancer/dt [Drug Therapy], breast cancer/th [Therapy], cell count, clinical article, drug efficacy, female, human, intravenous drug administration, male, metastasis/co [Complication], metastasis/dt [Drug Therapy], metastasis/th [Therapy], mobilization, neutrophil, peripheral blood stem cell, priority journal, stem cell, stem cell transplantation, subcutaneous drug administration, thrombocyte, thrombocytopenia/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cb [Drug Combination], antineoplastic agent/cm [Drug Comparison], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33559Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: cisplatin/dt [Drug Therapy], adult, aged, alopecia/co [Complication], alopecia/si [Side Effect], anemia/co [Complication], anemia/si [Side Effect], anorexia/si [Side Effect], article, bleeding/co [Complication], bleeding/si [Side Effect], cancer chemotherapy, cancer radiotherapy, cancer staging, cancer survival, clinical article, clinical trial, controlled clinical trial, controlled study, diarrhea/si [Side Effect], dose calculation, dose response, drug safety, edema/co [Complication], cisplatin/ae [Adverse Drug Reaction], cisplatin/cb [Drug Combination], cisplatin/do [Drug Dose], cisplatin/iv [Intravenous Drug Administration], paclitaxel/ae [Adverse Drug Reaction], paclitaxel/cb [Drug Combination], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], paclitaxel/iv [Intravenous Drug Administration], esophagitis/co [Complication], esophagitis/si [Side Effect], female, hiccup/si [Side Effect], human, human tissue, hyperglycemia/si [Side Effect], infection/si [Side Effect], insomnia/si [Side Effect], lung disease/si [Side Effect], lung non small cell cancer/dt [Drug Therapy], lung non small cell cancer/rt [Radiotherapy], lymphadenopathy, malaise/si [Side Effect], male, multimodality cancer therapy, muscle injury/co [Complication], nausea/co [Complication], nausea/si [Side Effect], neuropathy/si [Side Effect], neutropenia/co [Complication], neutropenia/si [Side Effect], phase 1 clinical trial, phase 2 clinical trial, pleura effusion, priority journal, radiation dose, radiation pneumonia/co [Complication], radiation response, thrombocytopenia/co [Complication], thrombocytopenia/si [Side Effect], tinnitus/si [Side Effect], treatment outcome, treatment planning, vomiting/co [Complication], vomiting/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/cb [Drug Combination], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/iv [Intravenous Drug Administration], carboplatin/ae [Adverse Drug Reaction], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32772Test
LibKey Link

مصطلحات الفهرس: promyelocytic leukemia/dt [Drug Therapy], amsacrine/cb [Drug Combination], amsacrine/dt [Drug Therapy], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], cytarabine/cb [Drug Combination], cytarabine/do [Drug Dose], cytarabine/dt [Drug Therapy], idarubicin/cb [Drug Combination], idarubicin/dt [Drug Therapy], retinoic acid/cb [Drug Combination], retinoic acid/do [Drug Dose], retinoic acid/dt [Drug Therapy], gene deletion, antineoplastic agent/cb [Drug Combination], adult, article, bone marrow, cancer combination chemotherapy, cancer recurrence, cancer regression, case report, chromosome deletion, clinical feature, controlled study, death, disease course, human, male, myelodysplasia, priority journal, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33043Test
LibKey Link

مصطلحات الفهرس: antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], antineoplastic agent/pd [Pharmacology], CD34 antigen/ec [Endogenous Compound], doxorubicin/ae [Adverse Drug Reaction], doxorubicin/ct [Clinical Trial], doxorubicin/cb [Drug Combination], doxorubicin/cm [Drug Comparison], doxorubicin/do [Drug Dose], doxorubicin/dt [Drug Therapy], doxorubicin/pd [Pharmacology], ifosfamide/ae [Adverse Drug Reaction], ifosfamide/ct [Clinical Trial], ifosfamide/cb [Drug Combination], ifosfamide/cm [Drug Comparison], ifosfamide/do [Drug Dose], ifosfamide/dt [Drug Therapy], ifosfamide/pd [Pharmacology], mesna/cb [Drug Combination], mesna/dt [Drug Therapy], paclitaxel/cb [Drug Combination], paclitaxel/cm [Drug Comparison], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], paclitaxel/pd [Pharmacology], recombinant granulocyte colony stimulating factor, thiotepa/cb [Drug Combination], thiotepa/dt [Drug Therapy], paclitaxel/ct [Clinical Trial], adult, antineoplastic activity, article, breast cancer/dt [Drug Therapy], breast cancer/th [Therapy], cell count, clinical article, drug efficacy, female, human, intravenous drug administration, male, metastasis/co [Complication], metastasis/dt [Drug Therapy], metastasis/th [Therapy], mobilization, neutrophil, peripheral blood stem cell, priority journal, stem cell, stem cell transplantation, subcutaneous drug administration, thrombocyte, thrombocytopenia/si [Side Effect], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/ct [Clinical Trial], antineoplastic agent/cb [Drug Combination], antineoplastic agent/cm [Drug Comparison], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33559Test
LibKey Link

مصطلحات الفهرس: drug efficacy, drug megadose, drug safety, drug tolerability, follicular lymphoma/dt [Drug Therapy], graft versus host reaction/co [Complication], human, immune response, immunogenicity, immunosuppressive treatment, in vivo study, mediator, multiple myeloma/dt [Drug Therapy], multiple myeloma/rt [Radiotherapy], multiple myeloma/th [Therapy], natural killer cell, nonhuman, plasmapheresis, priority journal, prognosis, regulatory T lymphocyte, review, T lymphocyte, treatment outcome, anthracycline/cb [Drug Combination], anthracycline/dt [Drug Therapy], anthracycline/pd [Pharmacology], antigen/ec [Endogenous Compound], antineoplastic agent/do [Drug Dose], antineoplastic agent/dt [Drug Therapy], bortezomib/dt [Drug Therapy], bortezomib/pd [Pharmacology], cancer vaccine/dt [Drug Therapy], corticosteroid/cb [Drug Combination], corticosteroid/do [Drug Dose], corticosteroid/dt [Drug Therapy], dendritic cell vaccine/dt [Drug Therapy], dendritic cell vaccine/pd [Pharmacology], fluorouracil/cb [Drug Combination], fluorouracil/dt [Drug Therapy], fluorouracil/pd [Pharmacology], gemcitabine/cb [Drug Combination], gemcitabine/dt [Drug Therapy], gemcitabine/pd [Pharmacology], granulocyte macrophage colony stimulating factor/cb [Drug Combination], granulocyte macrophage colony stimulating factor/dt [Drug Therapy], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], immunomodulating agent/dt [Drug Therapy], immunosuppressive agent/dt [Drug Therapy], interleukin 12/cb [Drug Combination], interleukin 12/dt [Drug Therapy], interleukin 6 antibody/dt [Drug Therapy], lenalidomide/cb [Drug Combination], lenalidomide/dt [Drug Therapy], lenalidomide/pd [Pharmacology], monoclonal antibody/dt [Drug Therapy], Pneumococcus vaccine, pomalidomide/cb [Drug Combination], pomalidomide/dt [Drug Therapy], pomalidomide/pd [Pharmacology], rituximab/dt [Drug Therapy], rituximab/pd [Pharmacology], taxane derivative/cb [Drug Combination], taxane derivative/dt [Drug Therapy], taxane derivative/pd [Pharmacology], thalidomide/cb [Drug Combination], thalidomide/dt [Drug Therapy], thalidomide/pd [Pharmacology], unclassified drug, immune paralysis, monoclonal antibody LeY/ct [Clinical Trial], monoclonal antibody LeY/dt [Drug Therapy], minimal residual disease, adoptive immunotherapy, allogeneic stem cell transplantation, antigen presentation, antineoplastic activity, apoptosis, autologous stem cell transplantation, cancer immunization, cancer radiotherapy, cell death, cell growth, cell proliferation, cell survival, cell therapy, clinical trial, cytotoxic T lymphocyte, dendritic cell, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30446Test
Immunotherapy
Click here for full text options
LibKey Link